NCPIC - National Cannabis Prevention and Information Centre

Publications Bulletin - July 2010

research publications

Relevant publications examining issues to do with cannabis that have been published in the last month include the following:

  • Adamson, S.J., Kay-Lambkin, F.J., Baker, A.L., Lewin, T.J., Thornton, L., Kelly, B.J., & Sellman, J.D. (2010). An improved brief measure of cannabis misuse: The Cannabis Use Disorders Identification Test-Revised (CUDIT-R). Drug and Alcohol Dependence 110, 137-143.
  • Böcker, K.B., Gerritsen, J., Hunault, C.C., Kruidenier, M., Mensinga, T.T., & Kenemans, J.L. (2010). Cannabis with high delta(9)-THC contents affects perception and visual selective attention acutely: An event-related potential study. Pharmacology, Biochemistry, and Behavior 96, 67-74.
  • Broséus, J., Anglada, F. & Esseiva, P. (2010). The differentiation of fibre- and drug type cannabis seedlings by gas chromatography/mass spectrometry and chemometric tools. Forensic Science International 200, 87-92.
  • Cawich, S.O., Downes, R., Martin, A.C., Evans, N.R., Mitchell, D.I., & Williams, E. (2010). Colonic perforation: A lethal consequence of cannabis body packing. Journal of Forensic and Legal Medicine 17, 269-271.
  • de Graaf, R., Radovanovic, M., van Laar, M., Fairman, B., Degenhardt, L., Aguilar-Gaxiola, S., Bruffaerts, R., de Girolamo, G., Fayyad, J., Gureje, O., Haro, J.M., Huang, Y., Kostychenko, S., Lépine, J.P., Matschinger, H., Mora, M.E., Neumark, Y., Ormel, J., Posada-Villa, J., Stein, D.J., Tachimori, H., Wells, J.E., & Anthony, J.C. (2010). Early cannabis use and estimated risk of later onset of depression spells: Epidemiologic evidence from the Population-based World Health Organization World Mental Health Survey Initiative. American Journal of Epidemiology 172, 149-159.
  • Decorte, T. (2010). The case for small-scale domestic cannabis cultivation. International Journal of Drug Policy 21, 271-275.
  • DeRosse, P., Kaplan, A., Burdick, K.E., Lencz, T., & Malhotra, A.K. (2010). Cannabis use disorders in schizophrenia: Effects on cognition and symptoms. Schizophrenia Research 120, 95-100.
  • Falenski, K.W., Thorpe, A.J., Schlosburg, J.E., Cravatt, B.F., Abdullah, R.A., Smith, T.H., Selley, D.E., Lichtman, A.H., & Sim-Selley, L.J. (2010). FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration. Neuropsychopharmacology 35, 1775-1787.
  • Gray, T.R., Barnes, A.J. & Huestis, M.A. (2010). Effect of hydrolysis on identifying prenatal cannabis exposure. Analytical and Bioanalytical Chemistry 397, 2335-2347.
  • Hathaway, A.D., Hyshka, E., Erickson, P.G., Asbridge, M., Brochu, S., Cousineau, M.M., Duff, C., & Marsh, D. (2010). Whither RDS? An investigation of Respondent Driven Sampling as a method of recruiting mainstream marijuana users. Harm Reduction Journal 7, 15.
  • Hesse, M., Tutenges, S. & Schliewe, S. (2010). The use of tobacco and cannabis at an international music festival. European Addiction Research 16, 208-212.
  • Laaris, N., Good, C.H. & Lupica, C.R. (2010). Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus. Neuropharmacology 59, 121-127.
  • McBride, O., Teesson, M., Slade, T., & Baillie, A. (2010). Theoretical and observed subtypes of DSM-IV alcohol- and cannabis-use disorders in the Australian population. Journal of Studies on Alcohol and Drugs 71, 597-606.
  • Proudfoot, H., Vogl, L., Swift, W., Martin, G., & Copeland, J. (2010). Development of a short cannabis problems questionnaire for adolescents in the community. Addictive Behaviors 35, 734-737.
  • Rettori, V., De Laurentiis, A. & Fernandez-Solari, J. (2010). Alcohol and endocannabinoids: Neuroendocrine interactions in the reproductive axis. Experimental Neurology 224, 15-22.
  • Rodrigo, C., Welgama, S., Gunawardana, A., Maithripala, C., Jayananda, G., & Rajapakse, S. (2010). A retrospective analysis of cannabis use in a cohort of mentally ill patients in Sri Lanka and its implications on policy development. Substance Abuse Treatment, Prevention and Policy 5, 16.
  • Sevy, S., Robinson, D.G., Napolitano, B., Patel, R.C., Gunduz-Bruce, H., Miller, R., McCormack, J., Lorell, B.S., & Kane, J. (2010). Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia. Schizophrenia Research 120, 101-107.
  • Spiga, S., Lintas, A., Migliore, M., & Diana, M. (2010). Altered architecture and functional consequences of the mesolimbic dopamine system in cannabis dependence. Addiction Biology 15, 266-276.
  • Stella, N. (2010). Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. Glia 58, 1017-1030.
  • Werb, D., Fischer, B. & Wood, E. (2010). Cannabis policy: Time to move beyond the psychosis debate. International Journal on Drug Policy 21, 261-264.
  • Wium-Andersen, I.K., Wium-Andersen, M.K., Becker, U., & Thomsen, S.F. (2010). Predictors of age at onset of tobacco and cannabis use in Danish adolescents. The Clinical Respiratory Journal 4, 162-167.
  • Wouters, M., Benschop, A. & Korf, D.J. (2010). Local politics and retail cannabis markets: The case of the Dutch coffee shops. International Journal on Drug Policy 21, 315-320.